Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • #EMA

    Tag: ema

    You Searched For "#EMA"
    AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

    AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

    Medical Dialogues Bureau31 March 2020 1:05 PM IST
    Lokelma is a highly selective, oral potassium-removing agent currently approved in the US, EU, Canada, Hong Kong, China, Russia, and Japan for the...
    EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma

    EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma

    Medical Dialogues Bureau4 March 2020 10:15 AM IST
    once-daily single inhaler triple therapy available for asthma and COPD if approved
    Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS

    Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS

    Medical Dialogues Bureau25 Feb 2020 1:03 PM IST
    "With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
    AbbVie gets positive CHMP Opinion for VENCLYXTO for Leukemia patients

    AbbVie gets positive CHMP Opinion for VENCLYXTO for Leukemia patients

    Medical Dialogues Bureau8 Feb 2020 10:00 AM IST
    New Delhi: AbbVie , a research-based global biopharmaceutical company, announced recently that the Committee for Medicinal Products for Human Use...
    Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

    Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

    MD bureau2 Feb 2020 10:00 AM IST
    Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) for a pre-filled syringe to administer Eylea® (aflibercept solution...
    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    Medical Dialogues Bureau21 July 2019 9:15 AM IST
    Sanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
    Tighter EU rules could trigger antibiotic shortage; says Fresenius

    Tighter EU rules could trigger antibiotic shortage; says Fresenius

    Medical Dialogues Bureau9 Jun 2019 9:00 AM IST
    Fresenius said that under the draft proposals, the bulk-freeze-dryers that is used to produce the antibiotic would have to be sterilised more...
    Pfizer acquires clinical-stage Biotech Therachon for $810 million

    Pfizer acquires clinical-stage Biotech Therachon for $810 million

    Garima12 May 2019 9:45 AM IST
    NEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 9:35 AM IST
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

    Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

    Farhat Nasim13 March 2019 1:49 PM IST
    Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
    GSK

    GSK's severe pediatric asthma drug wins European panel thumbs-up

    Ruby Khatun Khatun30 July 2018 10:00 AM IST
    GlaxoSmithKline (GSK) drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with...
    EMA accepts marketing authorization applications of Mylan and Biocon for 2 biosimilars

    EMA accepts marketing authorization applications of Mylan and Biocon for 2 biosimilars

    Ruby Khatun Khatun2 Dec 2017 10:00 AM IST
    HERTFORDSHIRE, England, PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the European Medicines Agency (EMA) has accepted for...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok